ContextVision AB (publ) (0L8Z) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Comtex Vision and thank you for joining our Q1 2025 webcast. Today with Richard Hallström, our CFO, and myself, Gerald. As usual, we'll give you an update on our business, we'll look into the financials and we'll close with a summary and outlook. Looking into the first quarter. The first clear highlight, which is also a very important milestone in the journey of the company, is the execution of a partnership agreement with the University of Washington in Seattle, United States. This is to support our journey in delivering and building digital organ-specific ultrasound-based biomarkers, a clear step forward in our journey towards data quality. In line with that partnership agreement and to enable clinical research, we have also executed investments into ultrasound equipment, which is going to be shipped in the second quarter to the University of Washington for clinical research. We have also seen ongoing fruitful collaboration with leading OEMs, expanding our footprint into the image processing chain. Financially, revenue came down to 26.3 million SEK, which is an adjusted EBITDA of 2.1 million SEK or 8.1%. Those investments in data quality are adjusted in those EBITDA figures. Overall, the first quarter was clearly impacted by seasonality, currency and the investments I mentioned. Now let's go a little bit more detailed into the operational highlights for the first quarter. As mentioned, we've attended the radiology conference in Vienna. Particularly when we discussed our opportunities in the image processing chain, which is a clear expansion of our service and product portfolio, we saw excellent feedback and leads for new customers and businesses. We can fairly state that we had a record number of customer meetings and also extended contracts with existin...